Pulmonary restriction predicts long-term pulmonary impairment in people with HIV and tuberculosis
- PMID: 33413293
- PMCID: PMC7791797
- DOI: 10.1186/s12890-020-01368-4
Pulmonary restriction predicts long-term pulmonary impairment in people with HIV and tuberculosis
Abstract
Background: While tuberculosis is considered a risk factor for chronic obstructive pulmonary disease, a restrictive pattern of pulmonary impairment may actually be more common among tuberculosis survivors. We aimed to determine the nature of pulmonary impairment before and after treatment among people with HIV and tuberculosis and identify risk factors for long-term impairment.
Methods: In this prospective cohort study conducted in South Africa, we enrolled adults newly diagnosed with HIV and tuberculosis who were initiating antiretroviral therapy and tuberculosis treatment. We measured lung function and symptoms at baseline, 6, and 12 months. We compared participants with and without pulmonary impairment and constructed logistic regression models to identify characteristics associated with pulmonary impairment.
Results: Among 134 participants with a median CD4 count of 110 cells/μl, 112 (83%) completed baseline spirometry at which time 32 (29%) had restriction, 13 (12%) had obstruction, and 9 (7%) had a mixed pattern. Lung function was dynamic over time and 30 (33%) participants had impaired lung function at 12 months. Baseline restriction was associated with greater symptoms and with long-term pulmonary impairment (adjusted odds ratio 5.44, 95% confidence interval 1.16-25.45), while baseline obstruction was not (adjusted odds ratio 1.95, 95% confidence interval 0.28-13.78).
Conclusions: In this cohort of people with HIV and tuberculosis, restriction was the most common, symptomatic, and persistent pattern of pulmonary impairment. These data can help to raise awareness among clinicians about the heterogeneity of post-tuberculosis pulmonary impairment, and highlight the need for further research into mediators of lung injury in this vulnerable population.
Keywords: HIV; Pulmonary disease; Respiratory function tests; Tuberculosis.
Conflict of interest statement
The authors declare that they have no competing interests.
Figures


References
-
- World Health Organization, Geneva, 2018.
MeSH terms
Substances
Grants and funding
- P30 AI050409/AI/NIAID NIH HHS/United States
- K23 AI134182/AI/NIAID NIH HHS/United States
- P30 AI051519/AI/NIAID NIH HHS/United States
- R01 AI120821/AI/NIAID NIH HHS/United States
- UM1 AI154463/AI/NIAID NIH HHS/United States
- P30AI045008/Center for AIDS Research, University of Pennsylvania
- P30AI050409/Center for AIDS Research, Emory University
- K23AI134182/Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases
- R01AI120821/Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials